133TiP: A randomized phase III study of ivonescimab versus pembrolizumab as first-line treatment of metastatic non-small cell lung cancer as first-line treatment of metastatic non-small cell lung cancer with high tumor PD-L1 expression: HARMONi-7Antonio Passaro, Antonio Calles, D. Rodriguez Abreu et al.|Journal of Thoracic Oncology|2025Cited by 1